Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extended Release (ER) / Long-acting (LA) Opioid Analgesics Risk Evaluation and Mitigation Strategy (REMS) Assessment 5.1: Surveillance of Emergency Department Visits and Hospitalizations for Opioid Overdose and Poisoning Events

NCT02866266 is registered in ClinicalTrials.gov with ER/LA Opioid REMS Program Companies (RPC) as lead sponsor.

NCT NCT02866266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02866266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extended Release (ER) / Long-acting (LA) Opioid Analgesics Risk Evaluation and Mitigation Strategy (REMS) Assessment 5.1: Surveillance of Emergency Department Visits and Hospitalizations for Opioid Overdose and Poisoning Events
Lead sponsor
ER/LA Opioid REMS Program Companies (RPC)
Phase
Observational
Overall status
Unknown status
Start date
Not reported
Completion date
Not reported
Enrollment
183,452 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

drug abuse, narcotic abuse, opioid addiction, opioid-related disorders